-
C.A. Cox
Section of Molecular Therapeutics,
National Eye Institute, Bethesda, MD
-
M. John–Aryankalayil
Section of Molecular Therapeutics,
National Eye Institute, Bethesda, MD
-
C. Jaworski
Section of Molecular Therapeutics,
National Eye Institute, Bethesda, MD
-
P. Russell
Aging and Ocular Diseases,
National Eye Institute, Bethesda, MD
-
T. Gray
Ophthalmology and Visual Sciences and Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX
-
K. Freedman
Ophthalmology and Visual Sciences and Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX
-
N. Dushku
Ophthalmology, Kaiser Permanente Medical Center, Sacramento, CA
-
T.W. Reid
Ophthalmology and Visual Sciences and Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX
-
D. Carper
Section of Molecular Therapeutics,
National Eye Institute, Bethesda, MD